1. Home
  2. BANC vs EVO Comparison

BANC vs EVO Comparison

Compare BANC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banc of California Inc.

BANC

Banc of California Inc.

N/A

Current Price

$18.51

Market Cap

3.1B

Sector

Finance

ML Signal

N/A

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$1.63

Market Cap

778.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BANC
EVO
Founded
1941
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
778.3M
IPO Year
2002
2007

Fundamental Metrics

Financial Performance
Metric
BANC
EVO
Price
$18.51
$1.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
1
Target Price
$21.83
$7.00
AVG Volume (30 Days)
2.1M
42.2K
Earning Date
04-22-2026
04-08-2026
Dividend Yield
2.63%
N/A
EPS Growth
125.00
N/A
EPS
N/A
N/A
Revenue
$1,818,792,000.00
N/A
Revenue This Year
$13.93
$1.37
Revenue Next Year
$8.03
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.33
$1.72
52 Week High
$21.93
$4.27

Technical Indicators

Market Signals
Indicator
BANC
EVO
Relative Strength Index (RSI) 44.51 27.66
Support Level $18.53 N/A
Resistance Level $19.16 $1.97
Average True Range (ATR) 0.38 0.04
MACD 0.03 -0.01
Stochastic Oscillator 44.93 8.11

Price Performance

Historical Comparison
BANC
EVO

About BANC Banc of California Inc.

Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: